SMARCA2 and adenocarcinoma: Although the loss of SMARCA2 was not significantly more frequent in HNF4α-positive adenocarcinomas, two of the four HNF4α-positive Grade 3 adenocarcinomas that expressed SMARCA4 showed the loss of SMARCA2.